Indivior
INDV
36.13
+0.23
+0.64%
Indivior
US · INDV
#2252 by market cap
Listed 1970
36.13
+0.23
+0.64%
Live - 5344 symbols - heartbeat 72s ago
· 2026-10-08 09:12
Pre-market
37.70
+4.35%
After-hours
36.13
0.00%
- Market cap
- 4.26B
- P/E (TTM)i
- 12.95
- P/Bi
- -20.60
- EPSi
- 1.64
- Div yieldi
- 0.00%
- 52W posi
- 65%
Reader sentiment
Are you bullish or bearish on INDV?
Anonymous reader poll. Unscientific, not investment advice.
About Indivior
Indivior Pharmaceuticals, Inc. is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company was founded on December 23, 2014 and is headquartered in North Chesterfield, VA.
- Founded
- 2014
- CEO
- Mr. Joe Ciaffoni
- Employees
- 838
- Headquarters
- North Chesterfield, Virginia, United States of America
- Fiscal year end
- 12-31
- Website
- indivior.com
Company profile
- Exchange
- US
- Symbol
- INDV
- Market-cap rank
- #2252
- Listing date
- 1970-01-01
- Market cap
- 4.26B
- Float cap
- 3.96B
- Shares out
- 118.03M
- Float shares
- 109.48M
Sectors & themes
Drug Manufacturers - Specialty & Generic
Fractional Shares JP
Quote time 2026-10-08 09:12:47 · For reference only, not investment advice and not tailored to your situation.